NO972613L - Anvendelse av additiver i kontrastmidler for å forbedre avbildning - Google Patents

Anvendelse av additiver i kontrastmidler for å forbedre avbildning

Info

Publication number
NO972613L
NO972613L NO972613A NO972613A NO972613L NO 972613 L NO972613 L NO 972613L NO 972613 A NO972613 A NO 972613A NO 972613 A NO972613 A NO 972613A NO 972613 L NO972613 L NO 972613L
Authority
NO
Norway
Prior art keywords
additives
contrast agents
improve imaging
imaging
improve
Prior art date
Application number
NO972613A
Other languages
English (en)
Norwegian (no)
Other versions
NO972613D0 (no
Inventor
Werner Krause
Ulrich Speck
Wolf-Ruediger Press
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO972613D0 publication Critical patent/NO972613D0/no
Publication of NO972613L publication Critical patent/NO972613L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/46—Unsaturated compounds containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/62—Unsaturated compounds containing ether groups, groups, groups, or groups containing rings other than six-membered aromatic rings
NO972613A 1994-12-09 1997-06-06 Anvendelse av additiver i kontrastmidler for å forbedre avbildning NO972613L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944446694 DE4446694A1 (de) 1994-12-09 1994-12-09 Verwendung von Zusätzen zu Kontrastmitteln zur Verbesserung der Bildgebung
PCT/EP1995/004826 WO1996017629A1 (de) 1994-12-09 1995-12-08 Verwendung von zusätzen zu kontrastmitteln zur verbesserung der bildgebung

Publications (2)

Publication Number Publication Date
NO972613D0 NO972613D0 (no) 1997-06-06
NO972613L true NO972613L (no) 1997-06-06

Family

ID=6537194

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972613A NO972613L (no) 1994-12-09 1997-06-06 Anvendelse av additiver i kontrastmidler for å forbedre avbildning

Country Status (6)

Country Link
EP (1) EP0789594A1 (de)
JP (1) JPH10509691A (de)
CA (1) CA2207025A1 (de)
DE (1) DE4446694A1 (de)
NO (1) NO972613L (de)
WO (1) WO1996017629A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9707081A (pt) * 1996-01-25 1999-05-25 Schering Ag Soluções de injeção e infusão concentradas aperfeiçoadas para aplicação intravasal
CA2340375A1 (en) * 1999-06-14 2000-12-21 Hiroshi Maeda Agent for enhancing accumulation of drugs in tumor tissues
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
CA2484383C (en) 2002-07-12 2016-05-31 Cook Incorporated Medical device coated with a bioactive agent
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450149A (en) * 1981-06-15 1984-05-22 Research Corporation Radiohalogenation method
JPH0669966B2 (ja) * 1989-07-05 1994-09-07 株式会社ミドリ十字 血管造影補助剤
US5334369A (en) * 1991-06-11 1994-08-02 Medical University Of South Carolina Platelet receptor antagonists useful in detecting intravascular platelet aggregation
DE4135193C1 (de) * 1991-10-22 1993-03-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De

Also Published As

Publication number Publication date
NO972613D0 (no) 1997-06-06
WO1996017629A1 (de) 1996-06-13
CA2207025A1 (en) 1996-06-13
DE4446694A1 (de) 1996-06-13
JPH10509691A (ja) 1998-09-22
EP0789594A1 (de) 1997-08-20

Similar Documents

Publication Publication Date Title
NO923821D0 (no) Diagnostiske midler
HUT67298A (en) Complexing agents, targeting radioactive immunoreagents having utility in therapeutic and diagnostic imaging compositions
NO173429C (no) Anvendelse av ferromagnetiske partikler i kontrastmidler for NMR-avbildning
NO980002L (no) Kaskadepolymerkomplekser, fremgangsmåte for fremstilling, samt farmasöytiske midler inneholdende disse
NO167077C (no) Diagnostiske midler for anvendelse ved in vivo NMR-diagnostikk, röntgendiagnostikk eller ultralyddiagnostikk.
NZ219079A (en) Metal complex salts and diagnostic preparations for use in nmr diagnosis
HK1030018A1 (en) Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
NL970040I1 (nl) Dipyridoxylfosfaten als contrastmiddelen bij de beeldvorming door kernmagnetische resonantie.
BG101024A (en) Monoclonal antibody active against cd44v6
FI945837A0 (fi) Mikrohiukkasia, menetelmä niiden valmistamiseksi ja niiden käyttö diagnostiikassa
ATE187340T1 (de) Kontrastmittel
NO972613L (no) Anvendelse av additiver i kontrastmidler for å forbedre avbildning
SE9402880D0 (sv) New peptide derivatives
DE69120826T2 (de) Chelatbildende mittel
TR199903144T2 (xx) Entraven�z kontrast maddelerinin projeksiyon mamografisi i�in kullan�l���
ATE315423T1 (de) Radiotherapeutische vorrichtung zur behandlung der prostata
FR2569569B1 (fr) Exerciseur destine notamment au travail du grand ecart.
ES2059779T3 (es) Compuestos anti-androgenos.
ATE134988T1 (de) Neue vorangeordnete sechszähnige liganden verwendbar in röntgenologischen bildformenden wirkstoffen
ATE106752T1 (de) Sichtbarmachung von tumoren mit technetiummarkierten kohlenhydraten.
NO972046L (no) Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike
ES2099613T3 (es) Empleo de hidroxinaftalinas en agentes colorantes.
GEU1999457Y (en) Method for Diagnosis of Formations in Kidneys
LAM The administration of cost accounting standards[Ph. D. Thesis]
MX9606108A (es) Anticuerpos monoclonales contra cd44v6.